Veröffentlichungen

Leitlinien:

1. Parsons JK, Dahm P, Köhler TS et al: Surgical management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA Guideline amendment 2020. J Urol 2020; 204: 799. Leitlinie anzeigen | Änderung 2020 anzeigen
   
   
2. European Association of Urology (EAU) guidelines on management of non-neurogenic male lower urinary tract symptoms (LUTS), including benign prostatic obstruction (BPO). Leitlinie anzeigen
   
   
3. Surgical and interventional management of benign prostatic obstruction: Guidelines from the Committee for Male Voiding Disorders of the French Urology Association. Prog Urol 2021; 31(5): 249-265. Kurzfassung anzeigen
   
   
4. NICE Medical Technologies Guidance (MTG58). UroLift for treating lower urinary tract symptoms of benign prostatic hyperplasia 2021.
   View Guidance
   
   
5. NICE Interventional Procedure Guidance (IPG475). Insertion of prostatic urethral lift implants to treat lower urinary tract symptoms secondary to benign prostatic hyperplasia. 2014. View Guidance

Meta-Analysen:

1. Tanneru K, Gautam S, Norez D, et al. Meta-analysis and systematic review of intermediate-term follow-up of prostatic urethral lift for benign prostatic hyperplasia. Int Urol Nephrol. 2020; 52(6): 999-1008. Kurzfassung anzeigen
   
   
2. Jing J, Wu Y, Du M, et al. Urethral Lift as a Safe and Effective Procedure for Prostatic Hyplasia Population: A Systematic Review and Meta-Analysis. Front Surg. 2020; 8(7): 598728. Artikel anzeigen
   
   
3. Perera M, Roberts MJ, Suhail ARD, Bolton D. Prostatic urethral lift improves urinary symptoms and flow while preserving sexual function for men with benign prostatic hyperplasia: a systematic review and meta-analysis. Eur Urol. 2015; 67; 704-713. Addendum Eur Urol 2015; 68; E53-E54. Kurzfassung anzeigen
   
   

Randomisierte, kontrollierte Studien:

1. L.I.F.T. Study
    
   1. Roehrborn CG, Barkin J, Gange SN, et al. Five year results of the prospective randomized controlled prostatic urethral L.I.F.T. study. Can J Urol. 2017; 24(3): 8802-8813. Artikel anzeigen
      
      
   2. Roehrborn CG. Prostatic Urethral Lift A Unique Minimally Invasive Surgical Treatment of Male Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia. Urol Clin N Am. 2016. 43:357-369. Kurzfassung anzeigen
      
      
   3. Roehrborn CG, Rukstalis DB, Barkin J, et al. Three year results of the prostatic urethral L.I.F.T. study. Can J Urol. 2015; 22(3): 7772-82.
      Artikel anzeigen
      
      
   4. Roehrborn CG, Gange SN, Shore ND, et al. Durability of the Prostatic Urethral Lift: 2-Year Results of the L.I.F.T. Study. Urology Practice. 2015; 2(1):26-32. Artikel anzeigen
      
      
   5. McVary KT, Gange SN, Shore ND. Treatment of LUTS secondary to BPH while preserving sexual function: randomized controlled study of prostatic urethral lift. J Sex Med. 2014; 11(1):279-87. Kurzfassung anzeigen
      
      
   6. Roehrborn CG, Gange SN, Shore ND, et al. The prostatic urethral lift for the treatment of lower urinary tract symptoms associated with prostate enlargement due to benign prostatic hyperplasia: the L.I.F.T. Study. J Urol. 2013; 190(6):2161-7. Kurzfassung anzeigen 
      
      
2. BPH6 Study
    
   1. Gratzke C, Barber N, Speakman MJ. Prostatic urethral lift vs transurethral resection of the prostate: 2-year results of the BPH6 prospective, multicentre, randomized study. BJU Int. 2017; 119(5):767-775. Artikel anzeigen
      
      
   2. Sonksen J, Barber NJ, Speakman MJ, et al. Prospective, randomized, multinational study of prostatic urethral lift versus transurethral resection of the prostate: 12-month results from the BPH6 study. Eur Urol. 2015; 68(4):643-52. Artikel anzeigen/herunterladen 
      
      

Nicht randomisierte, komparative Studien:

1. Roehrborn CG, Rukstalis DB. Prostatic Urethral Lift Versus Medical Therapy: Examining the Impact on Sexual Function in Men with Benign Prostatic Hyperplasia. Eur Urol Focus. 2021; S2405-4569(20) 30315-1. Artikel anzeigen
   
   
2. Tutrone RF, Schiff W. Early patient experience following treatment with the UroLift prostatic urethral lift and Rezum steam injection. Can J Urol. 2020; 27(3): 10213-10219. Artikel anzeigen 
   
   

Einarmige Studien:

1. MedLift Study
    
   1. Rukstalis D, Grier D, Stroup SP, et al. Prostatic Urethral Lift (PUL) for obstructive median lobes: 12 month results of the MedLift Study. Prostate Cancer Prostatic Dis. 2019; 22(3): 411-419. Artikel anzeigen
2. Crossover Study
    
   1. Rukstalis D, Rashid P, Bogache W, et al. 24-month durability after crossover to the prostatic urethral lift from randomised, blinded sham. BJU Int. 2016; 118(Suppl 3): 14-22. Artikel anzeigen
      
      
   2. Cantwell AL, Bogache WK, Richardson SF, et al. Multicentre prospective crossover study of the 'prostatic urethral lift' for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia. BJU Int. 2014; 113(4):615-22. Kurzfassung anzeigen 
3. LOCAL Study
    
   1. Shore N, Freedman S, Gange S, et al. Prospective multi-center study elucidating patient experience after prostatic urethral lift. Can J Urol. 2014; 21(1): 7094-101.* Artikel anzeigen
4. First-in-Human Study
    
   1. Chin PT, Bolton DM, Jack G, et al. Prostatic urethral lift: Two-year results after treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia. Urology. 2012; 79(1): 5-11.* Kurzfassung anzeigen
      
      
   2. Woo HH, Bolton DM, Laborde E. Preservation of sexual function with the prostatic urethral lift: a novel treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia. J Sex Med. 2012; 9(2):568-75. Kurzfassung anzeigen
      
      
   3. Woo HH, Chin PT, McNicholas TA. Safety and feasibility of the prostatic urethral lift: a novel, minimally invasive treatment for lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH). BJU Int. 2011; 108(1): 82-8. Kurzfassung anzeigen
5. Turkey Initial Study
    
   1. Bozkurt A, Karabakan M, Keskin E, Hirik E, Can Balci MB, Nuhoglu B. Prostatic Urethral Lift: A New Minimally Invasive Treatment for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia. Urol Int. 2016; 96(2): 202-206. Kurzfassung anzeigen
      
      
   2. Akin Y, Bozkurt A, Keles MO, Gulmez H, Sahin M, Nuhoglu B. A Novel Minimally Invasive Treatment Option for Benign Prostat Hyperplasia: Intraprostatic UroLift®, The First Case Series of Turkey with Short Term Follow-up. JAREM. 2013; 3: 74-8. Artikel anzeigen
6. France Initial Study
    
   1. Beurrier S, Peyromaure M, Belas O, Delongchamps NB. Are the UroLift® implants an alternative for the treatment of benign prostatic hyperplasia? Short-term results and predictive factors of failure. Prog Urol. 2015; 25: 523-529. Kurzfassung anzeigen
      
      
   2. Delongchamps NB, Conquy S, Zerbib M, Peyromaure M. Intra-prostatic UroLift(®) implants for benign prostatic hyperplasia: preliminary results of the four first cases performed in France. Prog Urol. 2012; 22(10): 590-7. Kurzfassung anzeigen
7. Spain Initial Study
    
   1. Garrido Abad P, Coloma Del Peso A, Sinues Ojas B, Fernandez Arjona M. Urolift®, a new minimally invasive treatment for patients with low urinary tract symptoms secondary to BPH. Preliminary results. Arch Esp Urol. 2013; 6696): 584-91. Kurzfassung anzeigen
8. Large, Retrospective Real-World Studies
    
   1. Rabinowitz MJ, Alam R, Liu JL, et al. Prostatic Urethral Lift in Patients With Obstructive Median Lobes: A Single Surgeon Experience at an Academic Center. Urology. 2021; S0090-4295(21): 00088. Kurzfassung anzeigen
      
      
   2. Eure G, Gange S, Walter P, et al. Real-World Evidence of Prostatic Urethral Lift Confirms Pivotal Clinical Study Results: 2-Year Outcomes of a Retrospective Multicenter Study. J Endourol. 2019; 33(7): 576-584. Artikel anzeigen
      
      
   3. Sievert KD, Schonthaler M, Berges R, et al. Minimally invasive prostatic urethral lift (PUL) efficacious in TURP candidates: a multicenter German evaluation after 2 years. World J Urol. 2019; 37(7):1353-1360. Artikel anzeigen
9. Chialastri P, Chialastri A, Mueller T. Does Prostatic Urethral Lift Reduce Urinary Medications? Trends in Medical Treatment Before and After Prostatic Urethral Lift. J Endourol. 2021; Jan 20. Kurzfassung anzeigen
   
   
10. Kim JH, Lee KS, Kim TH et al. Evaluation of Clinical Outcomes of Prostatic Urethral Lift for Benign Prostatic Hyperplasia: An Asian Population Study. World J Mens Health. 2020; 38(3):338-344. Artikel anzeigen
    
    
11. Userovici M, Ochoa A, Anract J, Beurrier S, Peyromaure M, Delongchamps NB. Prostatic urethral lift using Urolift® system for benign prostatic hyperplasia: 7 years experience. Prog Urol. 2020; 30(3): 147-154. Artikel anzeigen
    
    
12. Al-Singary W, Patel R, Obi-Njoku O, Patel HRH. The UroLift ® System for lower urinary tract obstruction: patient selection for optimum clinical outcome. Minim Invasive Ther Allied Technol. 2020; 11: 1-6. Kurzfassung anzeigen
    
    
13. Cayuelas Rubio C, Pallas Costa Y, Juan Escudero J, et al. Minimally invasive treatment for lower urinary tract symptoms due to benign prostatic hyperplasia. Our initial experience with Urolift® under local anaesthesia and sedation. Actas Urol Esp. 2019; 43(9): 488-494. Kurzfassung anzeigen
    
    
14. Shah BB, Tayon K, Madiraju S, Carrion RE, Perito P. Prostatic Urethral Lift: Does Size Matter? J Endourol. 2018; 32(7): 635-638. Kurzfassung anzeigen
    
    
15. Bardoli AD, Taylor WSJ, Mahmalji W. Can the UroLift prostatic implant device treat the symptoms of benign prostatic hypertrophy, avoid sexual dysfunction and reduce hospital TURP waiting times? A single centre, single surgeon experience and review of the literature. Aging Male. 2017; 20(3):192-197. Artikel anzeigen 
    
    

Technik-Beiträge:

1. Walsh LP. State of the art: Advanced techniques for prostatic urethral lift for the relief of prostate obstruction under local anesthesia. Can J Urol. 2017; 24(3):8859-8864. Artikel anzeigen 
   
   
2. McNicholas TA, Woo HH, Chin PT. Minimally invasive prostatic urethral lift: surgical technique and multinational experience. Eur Urol. 2013; 64(2): 292-9. Kurzfassung anzeigen 
   
   
3. Barkin J, Giddens J, Incze P. UroLift system for relief of prostate obstruction under local anesthesia. Can J Urol. 2012; 19(2):6217-22.
   Artikel anzeigen 
   
   

Gesundheitsökonomische Beiträge:

1. Clarke JL. Optimizing Population Health and Economic Outcomes: Innovative Treatment for BPH. Popul Health Manag. 2013; 16(Suppl 2): S1-S13. Artikel anzeigen